Brief: Inflarx Announces Public Offering Of Ordinary Shares
11/04/2023 21:05
InflaRx NV IF0G.F :
* INFLARX ANNOUNCES PUBLIC OFFERING OF ORDINARY SHARES
* INFLARX NV - INTENDS TO USE NET PROCEEDS FROM OFFERING TO
FUND
CONTINUED DEVELOPMENT OF VILOBELIMAB
Source text for Eikon: ID:nGNX7RN1Hr
Further company coverage: IF0G.F
Recent news on Inflarx NV
See all newsBrief: Inflarx NV Files For Offerng Of Ordinary Shares, Size Not Disclosed - SEC Filing
Brief: InflaRx Reports Full Year 2025 Results And Highlights Key Achievements And Expected Milestones
Brief: Inflarx Announces Late-Breaker Oral Presentation On Vilobelimab Phase 3 Results In Pyoderma Gangrenosum At 2026 American Academy Of Dermatology Annual Meeting
Brief: Inflarx NV Executing 30% Workforce Reduction
Brief: Inflarx Provides Update On Phase 3 Data Analyses For Vilobelimab In Pyoderma Gangrenosum